Chemiluminescence of pulmonary macrophages from patients with inactive sarcoidosis, in different radiological stages

Luminescence

Volumn 18, Issue 2, 2003, Pages 103-106

  Czuba, Zenon P ^a   Zydowicz, Grzegorz ^a   Ziora, Dariusz ^a   Cieslicki, Jan ^a   Oklek, Kazimierz ^a   Beck, Brygida ^a   Shani, Jashovam ^b,c   Krol, Wojciech ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Alveolar macrophages; Bronchoalveolar lavage; Chemiluminescence; Radiological staging of sarcoidosis; Sarcoidosis

Indexed keywords

MACROPHAGES; PATIENT TREATMENT; TUMORS;

ALVEOLAR MACROPHAGES; BRONCHOALVEOLAR LAVAGE; DURATION TIME; LUMINOLS; PHORBOL ESTERS; PHORBOL MYRISTATE ACETATES; RADIOLOGICAL STAGING OF SARCOIDOSIS; SARCOIDOSIS; STEROID THERAPY; TIME RANGE;

CHEMILUMINESCENCE;

PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER DERIVATIVE; STEROID; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; LUMINOL;

ARTICLE; CELL STIMULATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; DISEASE DURATION; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; RADIODIAGNOSIS; SARCOIDOSIS; SMOKING; VOLUNTEER; ADULT; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; FEMALE; KINETICS; MALE; METABOLISM; MIDDLE AGED; RADIOGRAPHY; STIMULATION;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; CELL SURVIVAL; CHEMILUMINESCENT MEASUREMENTS; FEMALE; HUMANS; INDICATORS AND REAGENTS; KINETICS; LUMINOL; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; SARCOIDOSIS; STIMULATION, CHEMICAL; TETRADECANOYLPHORBOL ACETATE;

EID: 0642378219     PISSN: 15227235     EISSN: 10991271     Source Type: Journal    
DOI: 10.1002/bio.711     Document Type: Article

References (30)

1. Crystal RG. NIH Conference, June 1978, Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes. Ann. Intern. Med. 1981; 94: 73-94.
2. Daniels RP, Dauber JH, Rossman MD. Immunologic abnormalities in sarcoidosis. Ann. Intern. Med. 1980; 92: 406-416.
3. Kim DS, Jeon YG, Shim TS et al. The value of interleukin-12 as an activity marker of pulmonary sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 2000; 17: 271-276.
4. Klebanoff SJ. Phagocytic cells: products of oxygen metabolism. In Inflammation: Basic Principles and Clinical Correlates, Gallin JI, Goldstein IM, Snyderman R (eds). Raven Press: New York, 1988; 391-444.
5. Johnston RB, Kitagawa S. Molecular basis for the enhanced respiratory burst of activated macrophages. Fed. Proc. 1985; 44: 2927-2932.
6. Nathan CF, Root RK. Hydrogen peroxide release from mouse peritoneal macrophages: dependence on sequential activation and triggering. J. Exp. Med. 1979; 146: 1648-1662.
7. Fantone JC, Ward PA. Experimental studies of immune complex injury to the lung (symposium on immune complex injury of the lung). Am. Rev. Resp. Dis. 1981; 124: 743-748.
8. Halliwel B. Reactive oxygen species in living systems: source, biochemistry and role in human disease. Am. J. Med. 1991; 91: 14s-22s.
9. Carp A, Janoff A. In vitro suppression of elastase inhibitory capacity by reactive oxygen species generated by phagocytosis of polymorphonuclear leukocytes. J. Clin. Invest. 1979; 63: 793-797.
10. Castranova V, Lee P, Ma JYC et al. Chemiluminescence from macrophages and monocytes. In Cellular Chemiluminescence, vol. II, Van Dyke K, Castranova V (eds). CRC Press: Boca Raton, 1987; 3-19.
11. Muller-Peddinghaus R. In vitro determination of phagocyte activity by luminol- and lucigenin-amplified chemiluminescence. Int. J. Immunopharmacol. 1984; 6: 455-466.
12. Williams AJ, Cole PJ. Investigation of alveolar macrophage function using lucigenin-dependent chemiluminescence. Thorax 1981; 36: 866-869.
13. Quanjer PH (ed.). Standardized lung function testing. Bull. Eur. Physiopathol. Resp. 1983; 19(5s):1-94.
14. Klech H, Hutter C (eds). Clinical guidelines and indications for bronchoalveolar lavage: report of the European Society of Pneumology Task Group on bronchoalveolar lavage. Eur. Resp. J. 1990; 3: 937-974.
15. Krol W, Czuba Z, Scheller S et al. Anti-oxidant property of ethanolic extract of propolis (EEP), as evaluated by inhibiting the chemiluminescence oxidation of luminol. Biochem. Intern. 1990; 21: 593-597.
16. Andersen BR, Brendzel AM. Use of a unique chemiluminescence spectrometer in a study of factors influencing granulocyte light emission. J. Immunol. Methods 1987; 19: 279-287.
17. Gescher A, Dale IL. Protein-kinase C - a novel target for rational anti-cancer drug design. Anti-cancer Drug Design 1989; 4: 93-105.
18. Martin RR, Lawrence EC, Teague RB, Gotlieb MS, Putman M. Chemiluminescence of lung macrophages and blood leucocytes in sarcoidosis. Am. Rev. Resp. Dis. 1986; 133: 298-301.
19. Ziora D, Dworniczek S, Niepsuj G et al. RANTES chemokine in bronchoalveolar lavage is indicated by high-resolution computed tomography in sarcoidosis patients. J. Bronchiol. 2002; 8: 173-179.
20. Conron M, DuBois RM. Immunological mechanisms in sarcoidosis. Clin. Exp. Allergy 2001; 31: 543-554.
21. Barth J, Entzian P, Petermann W. Increased release of free oxygen radicals by phagocytosing and nonphagocytosing cells from patients with active pulmonary sarcoidosis as revealed by luminol-dependent chemiluminescence. Klin. Wochenschr. 1988; 66: 292-297.
22. Calhoun WJ, Salisbury SM, Chosy LW, Busse WW. Increased alveolar macrophage chemiluminescence and airspace cell superoxide production in active pulmonary sarcoidosis. J. Lab. Clin. Med. 1988; 112: 147-156.
23. Winsel K, Christ R, Eckert H et al. Chemiluminescent measurements of alveolar macrophages in sarcoidosis patients. Z. Err. Atmungsorgane 1987; 169: 23-32.
24. Kelly CA, Ward C, Stenton SC, Hendrick DJ, Walters EH. Assessment of pulmonary macrophage and neutrophil function in sequential bronchoalveolar lavage aspirates in sarcoidosis. Thorax 1988; 43: 787-791.
25. Ward C, Kelly CA, Stenton SC, Duddridge MJ, Hendrick DJ. The relative contribution of bronchoalveolar macrophages and neutrophils to lucigenin- and luminol-amplified chemiluminescence. Eur. Resp. J. 1990; 3: 1008-1014.
26. Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA. Interstitial lung diseases of unknown cause. N. Engl. J. Med. 1984; 310: 235-244.
27. Lakari E, Paakko P, Kinnula VL. Manganese superoxide dismutase, but not CuZn superoxide dismutase, is highly expressed in the granulomas of pulmonary sarcoidosis and extrinsic allergic alveolitis. Am. J. Resp. Crit. Care Med. 1998; 158: 589-596.
28. Schuller-Levis GB, Sturman JA. Activation of alveolar leucocytes isolated from cats fed taurine-free diets. Adv. Med. Biol. 1992; 315: 83-90.
29. Marcinkiewicz J, Grabowska A, Bereta J, Stelmaszynska T. Taurine chloramine inhibits in vitro generation of nitric oxide and other macrophage inflammatory mediators. J. Leucocyte Biol. 1995; 58: 667-674.
30. Armstrong L, Foley NM, Millar AB. Inter-relationship between tumor TNFα and TNF soluble receptors in pulmonary sarcoidosis. Thorax 1999; 54: 534-540.